These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19643759)

  • 1. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.
    Sokka T; Kautiainen H; Pincus T; Toloza S; da Rocha Castelar Pinheiro G; Lazovskis J; Hetland ML; Peets T; Immonen K; Maillefert JF; Drosos AA; Alten R; Pohl C; Rojkovich B; Bresnihan B; Minnock P; Cazzato M; Bombardieri S; Rexhepi S; Rexhepi M; Andersone D; Stropuviene S; Huisman M; Sierakowski S; Karateev D; Skakic V; Naranjo A; Baecklund E; Henrohn D; Gogus F; Badsha H; Mofti A; Taylor P; McClinton C; Yazici Y
    Ann Rheum Dis; 2009 Nov; 68(11):1666-72. PubMed ID: 19643759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program.
    Grøn KL; Ornbjerg LM; Hetland ML; Aslam F; Khan NA; Jacobs JW; Henrohn D; Rasker JJ; Kauppi MJ; Lang HC; Mota LM; Aggarwal A; Yamanaka H; Badsha H; Gossec L; Cutolo M; Ferraccioli G; Gremese E; Bong Lee E; Inanc N; Direskeneli H; Taylor P; Huisman M; Alten R; Pohl C; Oyoo O; Stropuviene S; Drosos AA; Kerzberg E; Ancuta C; Mofti A; Bergman M; Detert J; Selim ZI; Abda EA; Rexhepi B; Sokka T
    Clin Exp Rheumatol; 2014; 32(6):869-77. PubMed ID: 25327997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.
    Sokka T; Kautiainen H; Pincus T; Verstappen SM; Aggarwal A; Alten R; Andersone D; Badsha H; Baecklund E; Belmonte M; Craig-Müller J; da Mota LM; Dimic A; Fathi NA; Ferraccioli G; Fukuda W; Géher P; Gogus F; Hajjaj-Hassouni N; Hamoud H; Haugeberg G; Henrohn D; Horslev-Petersen K; Ionescu R; Karateew D; Kuuse R; Laurindo IM; Lazovskis J; Luukkainen R; Mofti A; Murphy E; Nakajima A; Oyoo O; Pandya SC; Pohl C; Predeteanu D; Rexhepi M; Rexhepi S; Sharma B; Shono E; Sibilia J; Sierakowski S; Skopouli FN; Stropuviene S; Toloza S; Valter I; Woolf A; Yamanaka H;
    Arthritis Res Ther; 2010; 12(2):R42. PubMed ID: 20226018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
    Sokka T; Kautiainen H; Toloza S; Mäkinen H; Verstappen SM; Lund Hetland M; Naranjo A; Baecklund E; Herborn G; Rau R; Cazzato M; Gossec L; Skakic V; Gogus F; Sierakowski S; Bresnihan B; Taylor P; McClinton C; Pincus T;
    Ann Rheum Dis; 2007 Nov; 66(11):1491-6. PubMed ID: 17412740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study.
    Putrik P; Ramiro S; Keszei AP; Hmamouchi I; Dougados M; Uhlig T; Kvien TK; Boonen A
    Ann Rheum Dis; 2016 Mar; 75(3):540-6. PubMed ID: 25630346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
    Sokka T; Toloza S; Cutolo M; Kautiainen H; Makinen H; Gogus F; Skakic V; Badsha H; Peets T; Baranauskaite A; Géher P; Ujfalussy I; Skopouli FN; Mavrommati M; Alten R; Pohl C; Sibilia J; Stancati A; Salaffi F; Romanowski W; Zarowny-Wierzbinska D; Henrohn D; Bresnihan B; Minnock P; Knudsen LS; Jacobs JW; Calvo-Alen J; Lazovskis J; Pinheiro Gda R; Karateev D; Andersone D; Rexhepi S; Yazici Y; Pincus T;
    Arthritis Res Ther; 2009; 11(1):R7. PubMed ID: 19144159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: Influence of demographic factors.
    Duarte C; Santos E; Kvien TK; Dougados M; de Wit M; Gossec L; da Silva JAP
    Joint Bone Spine; 2021 Jan; 88(1):105071. PubMed ID: 32920168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inequities in access to biologic and synthetic DMARDs across 46 European countries.
    Putrik P; Ramiro S; Kvien TK; Sokka T; Pavlova M; Uhlig T; Boonen A;
    Ann Rheum Dis; 2014 Jan; 73(1):198-206. PubMed ID: 23467636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries.
    Laires PA; Exposto F; Mesquita R; Martins AP; Cunha-Miranda L; Fonseca JE
    Eur J Health Econ; 2013 Dec; 14(6):875-85. PubMed ID: 22986992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study.
    Putrik P; Ramiro S; Hifinger M; Keszei AP; Hmamouchi I; Dougados M; Gossec L; Boonen A
    Ann Rheum Dis; 2016 Apr; 75(4):715-20. PubMed ID: 26314921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of socioeconomic gradients within and between countries on health of patients with rheumatoid arthritis (RA): lessons from QUEST RA.
    Putrik P; Sokka T; Ramiro S; Boonen A
    Best Pract Res Clin Rheumatol; 2012 Oct; 26(5):705-20. PubMed ID: 23218433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.
    Sokka T; Envalds M; Pincus T
    Mod Rheumatol; 2008; 18(3):228-39. PubMed ID: 18437286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients.
    Dargham SR; Zahirovic S; Hammoudeh M; Al Emadi S; Masri BK; Halabi H; Badsha H; Uthman I; Mahfoud ZR; Ashour H; Gad El Haq W; Bayoumy K; Kapiri M; Saxena R; Plenge RM; Kazkaz L; Arayssi T
    PLoS One; 2018; 13(12):e0208240. PubMed ID: 30566451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries.
    Lucasson F; Kiltz U; Kalyoncu U; Leung YY; Palominos P; Cañete JD; Scrivo R; Balanescu A; Dernis E; Meisalu S; Ryussen-Witrand A; Soubrier M; Aydin SZ; Eder L; Gaydukova I; Lubrano E; Richette P; Husni E; Coates LC; de Wit M; Smolen JS; Orbai AM; Gossec L
    RMD Open; 2022 May; 8(1):. PubMed ID: 35523519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis Patients.
    Alivernini S; Tolusso B; Gessi M; Gigante MR; Mannocci A; Petricca L; Perniola S; Di Mario C; Bui L; Fedele AL; Capacci A; Bruno D; Peluso G; La Torre G; Federico F; Ferraccioli G; Gremese E
    Arthritis Rheumatol; 2021 Sep; 73(9):1601-1613. PubMed ID: 33750008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry.
    Schipper LG; Vermeer M; Kuper HH; Hoekstra MO; Haagsma CJ; Den Broeder AA; van Riel P; Fransen J; van de Laar MA
    Ann Rheum Dis; 2012 Jun; 71(6):845-50. PubMed ID: 22210852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study.
    Consolaro A; Giancane G; Alongi A; van Dijkhuizen EHP; Aggarwal A; Al-Mayouf SM; Bovis F; De Inocencio J; Demirkaya E; Flato B; Foell D; Garay SM; Lazăr C; Lovell DJ; Montobbio C; Miettunen P; Mihaylova D; Nielsen S; Orban I; Rumba-Rozenfelde I; Magalhães CS; Shafaie N; Susic G; Trachana M; Wulffraat N; Pistorio A; Martini A; Ruperto N; Ravelli A;
    Lancet Child Adolesc Health; 2019 Apr; 3(4):255-263. PubMed ID: 30819662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of etanercept plus methotrexate vs triple therapy in treating Chinese rheumatoid arthritis patients.
    Shi ZC; Fei HP; Wang ZL
    Medicine (Baltimore); 2020 Jan; 99(3):e16635. PubMed ID: 32011430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.